Te Aka Symposium speaker Josh McMillan in the news supporting Canteen
Revolutionary cancer drug developed in Auckland set to begin clinical trials
Professor Andrew Shelling’s recent trip to Spain for the EACR congress
Flagship research centres to tackle urgent societal challenges
